Chronic Pruritus of Unknown Origin (Investigational Adjunct)
Investigational adjunct for chronic pruritus of unknown origin after systemic workup; antihistamines, gabapentinoids, and (for select cases) systemic immunomodulators remain evidence-based.
Patienten-Zusammenfassung
- Ist dies FDA-zugelassen fuer diese Anwendung?
- Not FDA-cleared for chronic pruritus of unknown origin. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.
- Welche Evidenz existiert?
- Tier C (investigational). No controlled trials. Evidence-based first-line management is thorough workup for systemic causes (renal, hepatic, hematologic including polycythemia vera, thyroid, HIV, malignancy), skin examination for subtle dermatosis, emollients and antihistamines, gabapentin or pregabalin for neuropathic itch, antidepressants (mirtazapine, SSRIs) for chronic itch, dupilumab in select cases, and phototherapy.
- Hauptrisiken
- Bleeding from each bite site for 6 to 10 hours after the leech detaches
- Iron-deficiency anemia from cumulative blood loss across multiple sessions
- Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
- Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
- Permanent Y-shaped bite-mark scars or hyperpigmentation at attachment sites
- Local pain, bruising, swelling, or itching for 1 to 3 days after each session
- Itch worsening from new bite sites adding to cutaneous inflammation
- Delaying systemic workup that may identify treatable cause (lymphoma, polycythemia vera, cholestasis)
- Wer dies nicht in Betracht ziehen sollte
- Patients without comprehensive systemic workup (CBC, comprehensive metabolic panel, TSH, HIV, age-appropriate cancer screening)
- Patients with red-flag findings (weight loss, lymphadenopathy, night sweats) needing oncology workup
- Patients who have not tried antihistamines, gabapentinoids, and skin care
- Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, heparin, or daily aspirin used for medical reasons
- People with hemophilia or any other inherited bleeding disorder
- Patients with severe anemia (hemoglobin under 10 g/dL)
- People with an active infection at the planned application site
- Was Sie Ihren Kliniker fragen sollten
- Have I had a full workup for systemic causes of itch?
- Has age-appropriate cancer screening been completed (chronic itch can be a paraneoplastic symptom)?
- Have I tried antihistamines, gabapentin, and an antidepressant such as mirtazapine?
- Have phototherapy and dupilumab been considered?
- What is the published evidence base for leeches in idiopathic chronic pruritus?
- What is the plan if workup later reveals a systemic cause?
- Wann dringende medizinische Versorgung suchen
- Bleeding from a bite site that soaks through more than one dressing per hour
- Bleeding that continues more than 24 hours after the leech detached
- Spreading redness, warmth, swelling, pus, or red streaks around any bite site
- Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
- Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
- Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
- Unintentional weight loss, night sweats, swollen lymph nodes, or new fatigue (possible underlying malignancy)
- Yellowing of the skin or eyes, dark urine, or pale stools (possible liver disease)
Was dies NICHT bedeutet
- It does not mean leech therapy is FDA-cleared for chronic pruritus — the only FDA clearance is venous congestion in microsurgical reconstruction (K040187, June 2004).
- It does not replace systemic workup, which is the cornerstone of unexplained chronic itch.
- It does not treat underlying causes (cholestasis, polycythemia, lymphoma) that produce itch.
- It does not have RCT evidence in this indication.
- It may delay diagnosis of a serious underlying condition.
Sicherheits-Querverweise
Clinical Profile
- Category
- dermatological
- ICD-10
- L29.9, L29.8
- Safety tier
- low
Evidence Summary
Chronic pruritus is defined as itch lasting more than 6 weeks. Chronic pruritus of unknown origin (CPUO) is a diagnosis after thorough workup excludes primary dermatologic disease, systemic causes (renal, hepatic, hematologic, endocrine, malignancy, drug-induced), and neuropathic and psychogenic etiologies. Evidence-based management includes emollients, sedating antihistamines (mainly for sleep), gabapentinoids, mirtazapine, naltrexone, narrow-band UVB phototherapy, and emerging biologics. No published controlled trials of hirudotherapy exist for CPUO. Anecdotal reports describe localized application in regional itch with subjective short-term relief, possibly via local hyperemia and counterstimulation, with strong placebo overlay.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Incomplete systemic workup (rule out malignancy, renal, hepatic, hematologic causes first)
- Active excoriations or infected skin
- Psychogenic itch as primary diagnosis (refer to psychiatry)
- Severe atopic dermatitis where dupilumab is indicated
Related Conditions
Livedo Reticularis
Investigational use for primary livedo reticularis; very limited evidence. Secondary causes (lupus, APLAS) require rheumatology referral.
Lipodermatosclerosis
Investigational use for chronic lipodermatosclerosis; small case series suggest softening of fibrotic gaiter-area skin changes.
Insulin Injection Lipohypertrophy
Investigational use to soften and remodel insulin injection-related lipohypertrophy nodules; very limited evidence.
Androgenic Alopecia
Investigational use for androgenic alopecia; mechanism via local scalp perfusion improvement. Single-arm series only.